HLM TUBING SET W/BIOLINE COATING
Report
- Report Number
- 8010762-2016-00520
- Event Type
- Death
- Date Received
- August 18, 2016
- Date of Event
- July 28, 2016
- Report Date
- August 16, 2017
- Manufacturer
- MAQUET CARDIOPULMONARY AG
- Product Code
- DTZ
- PMA / PMN Number
- K101153
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- BR
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
A CLINICAL ASSESSMENT HAS BEEN PERFORMED. THE RESULTS ARE AS FOLLOWS: THE MANUFACTURER AGREES WITH THE USERS OPINION THAT THE AIR WAS GETTING INTO THE PLS-SET BY USE ERROR HANDLING A DIFFERENT MEDICAL PRODUCT (CENTRAL VENOUS CATHETER OR PRESSURE TRANSDUCER). THE PLS-SET HAS ACT AS SPECIFIED. MAQUET CARDIOPULMONARY (B)(4) REQUESTED THE PRODUCT FOR MANUFACTURERS LABORATORY INVESTIGATION BUT HAS NOT RECEIVED IT YET. INVESTIGATION IS STILL PENDING. A SUPPLEMENTAL MEDWATCH WILL BE SUBMITTED AS SOON AS FURTHER INFORMATION BECOMES AVAILABLE. ADDITIONAL INFORMATION: THE PRODUCT MENTIONED UNDER SECTION D IS NOT DISTRIBUTED TO THE US, BUT THE PRODUCT WITH CONTRIBUTING DESIGN FUNCTION TO THE AFFECTED COMPONENT (QUADROX-ID) IS REGISTERED UNDER 510(K): K101153.
THE SAMPLE WAS RETURNED TO THE SITE IN (B)(4) FOR INVESTIGATION. THE OXYGENATOR WAS DELIVERED WITHOUT THE VENOUS LINE AND IT WAS CONFIRMED BY THE SSU THAT THIS WAS UNAVAILABLE FOR RETURN. WITHOUT THIS COMPONENT, A FULL INVESTIGATION INTO THE ROOT CAUSE OF THE AIR ENTERING THE VENOUS LINE COULD NOT BE CARRIED OUT. HOWEVER A CLINICAL EVALUATION HAD ALREADY BEEN PERFORMED AND IT WAS DETERMINED THAT THE ISSUE WAS CAUSED BY USER ERROR DURING THE USE OF ANOTHER MEDICAL PRODUCT AS MENTIONED BY THE CUSTOMER IN THE FOLLOW-UP INFORMATION. THE PLS-SET HAS WORKED CORRECTLY AND THEREFORE THE FAILURE IS NOT CONFIRMED. NO SYSTEMIC ISSUE WAS IDENTIFIED FROM THE COMPLAINT DATABASE REVIEW BUT THE DATA, HOWEVER, WILL CONTINUE TO BE MONITORED AND IF A TREND OCCURS, IT WILL BE ESCALATED TO QUALITY ASSURANCE MANAGEMENT FOR REVIEW AND DETERMINATION IF FURTHER INVESTIGATION IS NECESSARY. DUE TO THIS NO FURTHER INVESTIGATION OR ACTION IS WARRANTED AT THIS TIME AND THE COMPLAINT WILL BE CLOSED. PLEASE NOTE THIS IS THE FINAL REPORT.
"ACCORDING TO THE SURGEON, WHICH WAS RESPONSIBLE FOR THE SURGERY, IT WAS OBSERVED AN EVENT ADVERSE, CAUSED BY AIR THAT ENTERED THE VENOUS LINE. THE DUTY PERFUSIONIST IMMEDIATELY DETECTED AIR INTO THE CIRCUIT AFTER THE WRONG OPENING THE TAP OF THE VENOUS ACCESS LINE PRESSURE TRANSDUCER." ADDITIONAL INFO: CUSTOMER THINKS THAT THE AIR WAS COMING THROUGH THE PORT OF LINE PRESSURE VENOUS ACCESS. VENOUS CANNULA 19 FR AND ARTERIAL CANNULA 17 FR WAS USED. CANNULA WAS PLACED ON FEMORAL ARTERY AND VEIN TO THE RIGHT. NO BUBBLE DETECTION WAS USED; ROTFLOW WAS USED IN MODE LPM AND RPM; A CENTRAL VENOUS ACCESS WAS EXISTING; IT WAS A ECMO ARTERIOVENOUS; CUSTOMER DOES NOT THINK THAT THE CLAIMED PRODUCT IS RESPONSIBLE FOR THE PATIENT DEATH. NO ANY OTHER ABNORMALITY WAS FOUND DURING USE. (B)(4).
(B)(4).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 538934 | HLM TUBING SET W/BIOLINE COATING | OXYGENATOR, CARDIOPULMONARY BYPASS | DTZ | MAQUET CARDIOPULMONARY AG | BE-PLS 2050 | 70112370 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 6 YR | Death |